- €99.55bn
- €98.40bn
- €27.72bn
- 91
- 13
- 92
- 77
Annual balance sheet for Safran SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,873 | 5,351 | 6,929 | 7,146 | 6,757 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7,855 | 8,807 | 10,113 | 11,809 | 13,439 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 18,188 | 20,583 | 24,785 | 29,375 | 31,523 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,678 | 4,543 | 4,413 | 4,703 | 5,282 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 39,533 | 41,716 | 46,828 | 50,468 | 55,012 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19,026 | 19,828 | 27,476 | 30,787 | 37,440 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 27,144 | 28,875 | 36,417 | 38,891 | 44,836 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 12,389 | 12,841 | 10,411 | 11,577 | 10,176 |
Total Liabilities & Shareholders' Equity | 39,533 | 41,716 | 46,828 | 50,468 | 55,012 |
Total Common Shares Outstanding |